An NIH grant will help support personalized medicine and patient-oriented research at UAB.
Published in People of UAB
The mechanism of widespread reorganization of DNA methylation may be a therapeutic target to prevent or reverse dyskinesia.
Published in Research
The biomarker, the protein kinase LRRK2, is a promising candidate for future exploration.
Published in Research
Results show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.
Published in Research
UAB joins with leading Parkinson’s disease organizations for a Birmingham conference.
Published in Campus
Preliminary results from UAB’s CBD oil studies show benefit in seizure control in some patients.
Published in Research
A key role for microRNA-155 in brain inflammation and neurodegeneration makes it both a potential therapeutic target and a biomarker for this progressive disorder.
Published in Research
Alabama ALS chapter honors UAB’s Peter King with Spirit of Lou Gehrig Award.
Published in People of UAB
More evidence that generic medications are as effective as brand name drugs.
Published in Research
UAB-led research shows how methylating an RNA binding protein leads to alternative RNA splicing. Mutant enzymes are often found in blood cancers.
Published in Research
Best of 2015 2The UAB studies are designed to test the safety and tolerability of CBD oil in patients with intractable seizures. CBD oil, a derivative of the cannabis plant, is delivered orally as an oily liquid.
Published in Health & Medicine
The Alzheimer’s plaques that accumulate around brain cells also congregate along the walls of blood vessels, according to UAB research, and that may contribute to cognitive issues.
Published in Research
Engineers, physicians, computer scientists and statisticians will collaborate to research and apply big data in the health care, industrial and smart cities fields.
Published in Research
A multisite study led by UAB has found the first biomarker for the onset of seizures in infants with tuberous sclerosis.
Published in Research
UAB's strengths in clinical care and research are powering an interdisciplinary expedition into largely uncharted territory: neuroinflammatory mechanisms in Parkinson's disease.
Published in Research

UAB’s Roberson wins young investigator award from the American Neurological Association.

Published in People of UAB
Oh honored with lifetime award from the American Association of Neuromuscular and Electrodiagnostic Medicine.
Published in People of UAB
Haydeh Payami, Ph.D., a leading geneticist recruited to the UAB-Hudson Alpha Center for Genomic Medicine and UAB Personalized Medicine Institute, is exploring the protective power of coffee and nicotine — and the mysteries of the microbiome — in Parkinson’s disease.
Published in Research
The drug inhibits the activity of a kinase enzyme called LRRK2, and it showed no pathology in rat lungs, kidneys or livers.
Published in Research
A new study from UAB suggests that the effect of genetic variants on warfarin dose differs by race – a step towards personalized medicine.
Published in Research
Page 3 of 7
Back to Top